0%

est. 2Y upside i

HealthcareSeries A

Throne is building the first wearable for your toilet that tracks gut health and hydration with every flush. Our mission is to improve health and, one day, save lives by making gut health as easy to track as sleep. Today, WHOOP for your poop – tomorrow, the smoke detector for colon cancer.

Rank

#2146

Sector

HealthTech

Est. Liquidity

~5Y

Data Quality

Data: Low

Throne is an extremely early-stage company with no disclosed revenue or valuation, making equity upside unquantifiable.

Last updated: July 19, 2026

Bull (15%)0%

If AI-driven wellness gains traction, Throne could dominate an emerging category; but without revenue or valuation data, upside is speculative.

Base (55%)0%

Given no revenue or valuation data, the median outcome is highly uncertain; likely requires further funding rounds diluting common stock.

Bear (30%)-100%

If product fails or regulation shifts, common stock becomes worthless given $20.1M in preferred liquidation preference.

Est. time to liquidity~5.0 years

Preference Stack Risk

severe

Funding Intensity

10000%

Total funding of $20.1M with an unknown valuation implies a potentially very high preference overhang, likely exceeding 50% of any estimated entry valuation.

Dilution Risk

high

Pre-revenue company will likely need additional funding rounds, diluting common stock significantly.

Secondary Liquidity

none

No secondary market data; likely no liquidity for employees.

Questions to Ask at the Interview

Strategic questions based on Throne's data — designed to show you've done your homework.

  • 1

    What is the current customer traction and unit economics?

  • 2

    How does Throne plan to navigate FDA/wellness product classification?

  • 3

    What is the projected revenue and valuation in the next 18 months?

Community

Valuation Sentiment

Our model estimates 0% upside. What do you think?

Anonymous. Do not share material non-public information.


Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.